Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelgenx Technologies Corp T.IGX

Alternate Symbol(s):  IGXT

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

Recent & Breaking News (TSX:IGX)

IntelGenx Reports Second Quarter 2022 Financial Results

GlobeNewswire August 11, 2022

IntelGenx to Report Second Quarter 2022 Financial Results on August 11, 2022 - Conference Call to Follow

GlobeNewswire August 4, 2022

IntelGenx Announces Completion of Share Issuance in Payment of Principal and Interest on Debentures

GlobeNewswire July 5, 2022

IIROC Trading Halt - IGX.DB

Canada NewsWire June 30, 2022

IntelGenx Announces Intention to Issue Shares in Payment of Principal and Interest on Outstanding Debentures

GlobeNewswire June 1, 2022

IntelGenx Reports First Quarter 2022 Financial Results

GlobeNewswire May 12, 2022

IntelGenx Announces Voting Results on Election of Directors and other items

GlobeNewswire May 10, 2022

IntelGenx to Report First Quarter 2022 Financial Results on May 12, 2022 - Conference Call to Follow

GlobeNewswire May 5, 2022

IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire April 26, 2022

IntelGenx Reports Fourth Quarter and Full-Year 2021 Financial Results

GlobeNewswire March 24, 2022

IntelGenx to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022 - Conference Call to Follow

GlobeNewswire March 17, 2022

IntelGenx Receives Third Loan Tranche from atai

GlobeNewswire February 1, 2022

First Patient Dosed in IntelGenx's Resumed 'BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease

GlobeNewswire January 20, 2022

IntelGenx (TSX:IGX) initiates an arbitration proceeding

Brieanna McCutcheon  December 8, 2021

IntelGenx Initiates Arbitration Proceeding Against Tilray® Related to an Alleged Breach of Worldwide Cannabis-Infused VersaFilm® Agreement

GlobeNewswire December 8, 2021

IntelGenx Reports Third Quarter 2021 Financial Results

GlobeNewswire November 11, 2021

IntelGenx to Report Third Quarter 2021 Financial Results on November 11, 2021 - Conference Call to Follow

GlobeNewswire November 4, 2021

IntelGenx Technologies Corp. Virtually Opens the Market

PR Newswire October 12, 2021

Patient Screening to Resume in IntelGenx's 'BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease

GlobeNewswire October 12, 2021

IntelGenx (TSXV:IGX) graduates to the Toronto Stock Exchange

John Ballem  October 5, 2021